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eal-Time  Elastography  in the Assessment  of Advanced
ibrosis in  Chronic  Hepatitis  C: Is It Here  to Stay?
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eiver  ﬁbrosis  is,  undoubtedly,  one  of  the  main  prognostic  fac-
ors  in  liver  disease  because  it  determines  the  development
f  cirrhosis  and  its  subsequent  complications.1
Classically,  liver  biopsy  has  been  considered  the
old-standard  for  liver  ﬁbrosis  assessment.2 There  are  lim-
tations  associated  to  liver  biopsy,  namely  sampling  bias,
bserver  variability  among  pathologists  and  potentially  life-
hreatening  complications.3 Moreover,  information  provided
y  histological  evaluation  of  the  liver  tissue  obtained  at
iopsy  is  static,  incapable  of  transmitting  dynamic  or  func-
ional  regarding  liver  disease.
A  number  of  non-invasive  diagnostic  tools  for  liver  ﬁbrosis
valuation  have  emerged  in  the  last  decade,  and  are  gener-
lly  deﬁned  as  serological  or  mechanical.  The  most  studied
lood  marker  based  indices  include  FibroTest,  Fibrosis-4
ndex,  Forns  Score,  aspartate-to-platelet-ratio  APRI  score
nd  ELF  score.  Among  mechanical  methods  are  transient
lastography  (TE),  MR  elastography,  acoustic  radiation  force
mpulse  (ARFI),  shear  wave  elastography  (SWE)  and  real-
ime  elastography  (RTE).4
Real-time  elastography  is  an  imaging  method  that  uses
onventional  ultrasound  (US)  probes  to  detect  the  physicalDOI of original article:
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lastograms  in  order  to  acquire  semi-quantitative  data.
inear  probes  are  more  commonly  used  because  they  are
nchanged  by  depth-related  distortion  and  B-mode  position-
ng  allows  for  selection  of  the  region  of  interest.5 During  the
TE  module,  the  operator’s  compression  transmits  a  strain
ithin  the  liver  parenchyma  and  a  strain  proﬁle  is  calcu-
ated  along  the  compressed  area.6 New  RTE  technology  does
ot  require  compression  and  can  compute  the  automatic
train  generated  by  the  heartbeat.7 In  order  to  interpret
he  results  two  ﬁbrosis  indexes,  Japanese  and  German,  have
een  developed  based  upon  the  analysis  of  the  histogram.8,9
Over  the  last  7  years,  several  studies  have  been  pub-
ished  validating  RTE  for  evaluation  of  liver  ﬁbrosis  in  diverse
iver  diseases  and  comparing  it  with  other  diagnostic  modal-
ties.  One  of  the  main  limitations  highlighted  by  authors  is
ts  lower  reproducibility  compared  to  TE.10 Previous  studies
ave  concluded  that  in  viral  hepatitis  (HCV  and  HBV)  and
on-alcoholic  steatohepatitis,  the  elastic  ratio  method  has
 good  correlation  with  liver  biopsy,  particularly  in  those
ith  signiﬁcant  ﬁbrosis  (METAVIR  score  F  ≥  2),7,9,11,12 having
urpassed  blood  markers  in  diagnostic  accuracy.13 Morikawa
t  al.12 demonstrated  that  the  RTE  ﬁbrosis  index  was  partic-
larly  accurate  for  individuals  with  F  ≥  2.  On  distinguishing
igniﬁcant  from  non-signiﬁcant  ﬁbrosis  in  chronic  hepatitis
 (CHC)  patients,  Ferraioli  et  al.7 showed  that  RTE  ﬁbrosis
ndex  was  inferior  to  TE  and  APRI.  Tamaki  et  al.,14 on  the
dade Portuguesa de Gastrenterologia. This is an open access article
y-nc-nd/4.0/).
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contrary  found  that  in  patients  with  CHC,  RTE  liver  ﬁbrosis
index  was  a  very  accurate  tool  in  predicting  advanced  ﬁbro-
sis  (F  ≥  3)  and  outperformed  blood  markers  (APRI,  FIB-4)  in
diagnostic  capacity.  A  recent  meta-analysis  reported  diag-
nostic  accuracy  for  individuals  with  signiﬁcant  ﬁbrosis,  and
underlined  that  RTE  was  not  highly  accurate  for  establishing
cut-off  stages  of  ﬁbrosis.15 The  data  supporting  a  role  for
RTE  in  diagnostic  algorithm  of  liver  ﬁbrosis  in  CHC  patients
has  been  conﬂicting.
Marques  et  al.  set  out  to  determine  its  diagnostic  accu-
racy,  compare  the  RTE  liver  ﬁbrosis  index  with  serological
markers  and  detect  if  anthropometric  features  signiﬁcantly
inﬂuenced  histogram  acquisition.16 In  this  small  prospective
study,  32  patients  had  successfully  obtained  RTE  histogram
analysis.  One  of  the  main  ﬁndings  detected  in  this  study  per-
tains  to  one  of  the  limitations  of  this  tool.  In  this  cohort  of
patients  those  with  higher  BMIs  and  abdominal  wall  thick-
ness  ≥23  mm  had  signiﬁcantly  lower  histogram  acquisition
rates.  This  is  an  important  point  because  it  likens  RTE  to  TE
in  its  incapacity  to  evaluate  patients  with  abdominal  obe-
sity.  In  addition,  this  study  has  conﬁrmed  that  RTE  is  a  useful
tool  to  detect  advanced  or  signiﬁcant  liver  ﬁbrosis  corrob-
orating  data  found  in  previous  studies  comparing  RTE  liver
ﬁbrosis  index  to  other  methodologies.  RTE  does  not  have
high  accuracy  to  select  a  cut-off  for  grade  of  ﬁbrosis.  This
is  probably  one  of  the  most  important  shortcomings  associ-
ated  to  RTE.  While  with  other  non-invasive  methods,  such
as  TE  and  blood  markers,  cut-offs  have  been  established  for
diverse  liver  diseases,  the  same  does  not  hold  true  for  RTE.
Due  to  some  important  deﬁciencies  of  RTE,  it  is  not
currently  an  optimal  global  tool  for  liver  ﬁbrosis  staging.
Advances  in  technology  may  increase  its  applicability  in  the
future.
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